For women, urinary incontinence and other related lower urinary tract symptoms (e.g. nocturia, urinary urgency, frequency) are common, often increasing in frequency as women age. Urinary incontinence, however, is more than just a physiologic loss of urine. Emotional distress is also a significant issue for incontinent individuals. Researchers and clinicians are increasingly aware of the… Read More
Follicle stimulating hormone, estradiol, anti-Mullerian hormone and inhibin B in the menopausal transition
Three recent publications [1-3] have documented longitudinal changes in the circulating concentrations of follicle stimulating hormone (FSH), estradiol, anti-Mullerian hormone (AMH), also called Mullerian inhibiting substance (MIS), and inhibin B over approximately 10 years before the final menstrual period (FMP), with additional data for FSH and estradiol in the 10 following years. The hormone measurements… Read More
Metabolic syndrome in the menopausal transition
Metabolic syndrome (MetS) is a constellation of metabolic risk factors for cardiovascular disease in one individual. The more risk categories identified, the higher the potential risk. The diagnosis of MetS is based on the presence of three or more risk categories found in the same person [1]. Assessment and management of MetS become an important… Read More
